Handelsbanken Fonder
RLAY icon

Handelsbanken Fonder’s Relay Therapeutics RLAY Stock Holding History

Handelsbanken Fonder’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11M Buy
+59,100
New +$858K ﹤0.01% 1085
2024
Q2 		– Sell
-39,200
Closed -$325K – 1579
2024
Q1 		$325K Buy
39,200
+9,700
+33% +$94.6K ﹤0.01% 1360
2023
Q4 		$325K Buy
29,500
+1,600
+6% +$13.5K ﹤0.01% 1359
2023
Q3 		$235K Hold
27,900
– – ﹤0.01% 1400
2023
Q2 		$350K Buy
27,900
+4,400
+19% +$54.7K ﹤0.01% 1265
2023
Q1 		$387K Hold
23,500
– – ﹤0.01% 1138
2022
Q4 		$351K Buy
+23,500
New +$450K ﹤0.01% 1161
2022
Q2 		– Sell
-8,500
Closed -$254K – 1680
2022
Q1 		$254K Sell
8,500
-5,400
-39% -$131K ﹤0.01% 1575
2021
Q4 		$427K Buy
+13,900
New +$439K ﹤0.01% 1461

Other funds holding RLAY

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return